The impact of the localisation of endometriosis lesions on ovarian reserve and assisted reproduction techniques outcomes

References

• Al-Azemi M, Bernal AL, Steele J, Gramsbergen I, Barlow D, Kennedy S. 2000. Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis. Human Reproduction (Oxford, England) 15:72–75.
   PubMed Web of Science ®Google Scholar
• Almog B, Shehata F, Sheizaf B, Tan SL, Tulandi T. 2011. Effects of ovarian endometrioma on the number of oocytes retrieved for in vitro fertilization. Fertility and Sterility 95:525–527.
   PubMed Web of Science ®Google Scholar
• American Society for Reproductive Medicine. 1997. Revised American Society for Reproductive Medicine Classification of Endometriosis: 1996. Fertility and Sterility 67:817–821.
   PubMed Web of Science ®Google Scholar
• Azem F, Lessing JB, Geva E, Shahar A, Lerner-Geva L, Yovel I, et al. 1999. Patients with stages III and IV endometriosis have a poorer outcome of in vitro fertilization-embryo transfer than patients with tubal infertility. Fertility and Sterility 72:1107–1109.
   PubMed Web of Science ®Google Scholar
• Barbosa MA, Teixeira DM, Navarro PA, Ferriani RA, Nastri CO, Martins WP. 2014. Impact of endometriosis and its staging on assisted reproduction outcome: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology 44:261–278.
   PubMed Web of Science ®Google Scholar
• Benaglia L, Pasin R, Somigliana E, Vercellini P, Ragni G, Fedele L. 2011. Unoperated ovarian endometriomas and responsiveness to hyperstimulation. Human Reproduction (Oxford, England) 26:1356–1361.
   PubMed Web of Science ®Google Scholar
• Biasoni V, Patriarca A, Dalmasso P, Bertagna A, Manieri C, Benedetto C, et al. 2011. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reproductive Biology and Endocrinology: Rb&E 9:112.
   PubMed Web of Science ®Google Scholar
• Carrillo L, Seidman DS, Cittadini E, Meirow D. 2016. The role of fertility preservation in patients with endometriosis. Journal of Assisted Reproduction and Genetics 33:317–323.
   PubMed Web of Science ®Google Scholar
• Chapron C, Pietin-Vialle C, Borghese B, Davy C, Foulot H, Chopin N. 2009. Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis. Fertility and Sterility 92:453–457.
   PubMed Web of Science ®Google Scholar
• Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G. 2011. Ovarian surgery for bilateral endometriomas influences age at menopause. Human Reproduction (Oxford, England) 26:3000–3007.
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Borghese B, Chapron C. 2010a. Endometriosis and infertility: pathophysiology and management. Lancet (London, England) 376:730–738.
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Gayet V, Aubriot FX, Fauque P, Streuli I, Wolf JP, et al. 2010b. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertility and Sterility 94:2796–2799.
   PubMed Web of Science ®Google Scholar
• Dong X, Liao X, Wang R, Zhang H. 2013. The impact of endometriosis on IVF/ICSI outcomes. International Journal of Clinical and Experimental Pathology 6:1911–1918.
   PubMed Web of Science ®Google Scholar
• Dubuisson JB, Chapron C. 1994. Classification of endometriosis. The need for modification. Human Reproduction (Oxford, England) 9:2214–2216.
   PubMed Web of Science ®Google Scholar
• Esinler I, Bozdag G, Arikan I, Demir B, Yarali H. 2012. Endometrioma </=3 cm in diameter per se does not affect ovarian reserve in intracytoplasmic sperm injection cycles. Gynecologic and Obstetric Investigation 74:261–264.
   PubMed Web of Science ®Google Scholar
• Ghaffari F, Arabipoor A, Bagheri Lankarani N, Hosseini F, Bahmanabadi A. 2016. Hysteroscopic polypectomy without cycle cancellation in IVF/ICSI cycles: a cross-sectional study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 205:37–42.
   PubMed Web of Science ®Google Scholar
• Hamdan M, Dunselman G, Li TC, Cheong Y. 2015. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Human Reproduction Update 21:809–825.
   PubMed Web of Science ®Google Scholar
• Hirokawa W, Iwase A, Goto M, Takikawa S, Nagatomo Y, Nakahara T, et al. 2011. The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Human Reproduction (Oxford, England) 26:904–910.
   PubMed Web of Science ®Google Scholar
• Huber M, Hadziosmanovic N, Berglund L, Holte J. 2013. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Fertility and Sterility 100:1270–1276.e3.
   PubMed Web of Science ®Google Scholar
• Hwu YM, Wu FS, Li SH, Sun FJ, Lin MH, Lee RK. 2011. The impact of endometrioma and laparoscopic cystectomy on serum anti-Mullerian hormone levels. Reproductive Biology and Endocrinology 9:80.
   PubMed Web of Science ®Google Scholar
• Iwase A, Hirokawa W, Goto M, Takikawa S, Nagatomo Y, Nakahara T, et al. 2010. Serum anti-Müllerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve . Fertility and Sterility 94:2846–2849.
   PubMed Web of Science ®Google Scholar
• Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. 2013. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Science Translational Medicine 5:185ra62.
   PubMed Web of Science ®Google Scholar
• Kim JY, Jee BC, Suh CS, Kim SH. 2013. Preoperative serum anti-Mullerian hormone level in women with ovarian endometrioma and mature cystic teratoma. Yonsei Medical Journal 54:921–926.
   PubMed Web of Science ®Google Scholar
• Kuroda K, Kitade M, Kikuchi I, Kumakiri J, Matsuoka S, Kuroda M, et al. 2009. The impact of endometriosis, endometrioma and ovarian cystectomy on assisted reproductive technology. Reproductive Medicine and Biology 8:113–118.
   PubMedGoogle Scholar
• Kwee J, Schats R, McDonnell J, Themmen A, De Jong F, Lambalk C. 2008. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve . Fertility and Sterility 90:737–743.
   PubMed Web of Science ®Google Scholar
• Li HWR, Lee VCY, Ho PC, Ng EHY. 2014. Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment. Journal of Assisted Reproduction and Genetics 31:199–203.
   PubMed Web of Science ®Google Scholar
• Madani T, Ghaffari F, Kiani K, Hosseini F. 2009. Hysteroscopic polypectomy without cycle cancellation in IVF cycles. Reproductive Biomedicine Online 18:412–415.
   PubMed Web of Science ®Google Scholar
• Matalliotakis IM, Cakmak H, Mahutte N, Fragouli Y, Arici A, Sakkas D. 2007. Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility. Fertility and Sterility 88:1568–1572.
   PubMed Web of Science ®Google Scholar
• Meden-Vrtovec H, Tomazevic T, Verdenik I. 2000. Infertility treatment by in vitro fertilization in patients with minimal or mild endometriosis. Clinical and Experimental Obstetrics & Gynecology 27:191–193.
   PubMedGoogle Scholar
• Meirow D, Dor J, Kaufman B, Shrim A, Rabinovici J, Schiff E, et al. 2007. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Human Reproduction (Oxford, England) 22:1626–1633.
   PubMed Web of Science ®Google Scholar
• Roness H, Gavish Z, Cohen Y, Meirow D. 2013. Ovarian follicle burnout: a universal phenomenon? Cell Cycle (Georgetown, TX) 12:3245–3246.
   PubMed Web of Science ®Google Scholar
• Sanchez A, Vigano P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. 2014. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Human Reproduction Update 20:217–230.
   PubMed Web of Science ®Google Scholar
• Shebl O, Ebner T, Sommergruber M, Sir A, Tews G. 2009. Anti Muellerian hormone serum levels in women with endometriosis: a case-control study. Gynecological Endocrinology 25:713–716.
   PubMed Web of Science ®Google Scholar
• Somigliana E, Berlanda N, Benaglia L, Vigano P, Vercellini P, Fedele L. 2012. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertility and Sterility 98:1531–1538.
   PubMed Web of Science ®Google Scholar
• Somigliana E, Infantino M, Benedetti F, Arnoldi M, Calanna G, Ragni G. 2006. The presence of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins. Fertility and Sterility 86:192–196.
   PubMed Web of Science ®Google Scholar
• Streuli I, De Ziegler D, Gayet V, Santulli P, Bijaoui G, De Mouzon J, et al. 2012. In women with endometriosis anti-Müllerian hormone levels are decreased only in those with previous endometrioma surgery. Human Reproduction (Oxford, England) 27:3294–3303.
   PubMed Web of Science ®Google Scholar
• Tremellen K, Kolo M. 2010. Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy. The Australian & New Zealand Journal of Obstetrics & Gynaecology 50:568–572.
   PubMed Web of Science ®Google Scholar
• Uncu G, Kasapoglu I, Ozerkan K, Seyhan A, Oral Yilmaztepe A, Ata B. 2013. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Human Reproduction (Oxford, England) 28:2140–2145.
   PubMed Web of Science ®Google Scholar
• Yang C, Geng Y, Li Y, Chen C, Gao Y. 2015. Impact of ovarian endometrioma on ovarian responsiveness and IVF: a systematic review and meta-analysis. Reproductive BioMedicine Online 31:9–19.
   PubMed Web of Science ®Google Scholar
• Zegers-Hochschild F, Adamson GD, De Mouzon J, Ishihara O, Mansour R, Nygren K, et al. 2009. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Human Reproduction (Oxford, England) 24:2683–2687.
   PubMed Web of Science ®Google Scholar